Recent Finacing
Recent Raise
Hephaistos-Pharma is a preclinical biotech developing ONCO-Boost, an intravenous immunostimulant that activates innate immunity to treat metastatic and hard-to-treat solid tumors including sarcoma; operations in Lyon and Liège.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
